At i3 Consult we employ a number of strategic, financial and operational management tools to further your understanding of where your product is heading in the healthcare market, and the corrective action needed for your business/product portfolio.
Strategic Marketing Services – Customised Surveys & Speciality Reports, e.g. eHealth, Healthcare Brands, Regulatory Developments – see i3 Reports
Value Chain Analysis : Identifying key activities within (e.g. bulk material procurement) and around (e.g. raising pharmaceutical sales levels via innovative web based interfaces) your organization and identify them with the competitive strength of your healthcare product or service.
Life Cycle Analysis : Whether your launch is still under post marketing surveillance or you’re seeking to extend an existing therapeutic line, we will assess whether your chosen strategy is appropriate given the stage of the product’s lifecycle and those of competitors in the same therapeutic class.
i3 Framework Approach : Different countries have different pharmacoeconomic systems for evaluating the efficient use of healthcare resources, here we clarify the profitability of your chosen market through frameworks such as Porter’s Five Forces, McKinsey’s 7Ss, BCG Analysis, Strategic Clocking and other in-house models
Financial Management Services : Corporate Profiling using Financial Ratios, e.g. Current Asset Turnover Rates (Sales/Total Current Assets), Acid Test Ratios (Cash/Current Liabilities) & Capital Gearing Ratios (Debt Capital/Capital Interests) to harvest, hold, grow, turnaround or find niche with your current product portfolio. Product and R&D Investment Appraisal in terms of Net Present Value and Internal Rate of Return
R & D Manufacturing Consultancy : Chemical Bulk Manufacturing Consultancy – Inventory Control, Chain Management, Working Capital Issues, “Make or Buy” Decisions, Batch, Combinatorial & Flow-line Processes
